In this study, we set up and developed a tachypaced dog model of AF, to investigate the possible changes in different potassium channels—including Ito, IK1 and IK,Ach—which, based on previous reports, are considered to be the main pharmacological targets in AF treatments [1,2]. This evidence concerns the gene FGFR3 and atrial fibrillation.